Shizhen Li

283 Tongzipo Road
Changsha, 410013, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

ABHD11-AS1 Suppresses Colorectal Cancer Progression by Disrupting EIF4E-mediated POU2F1 Ubiquitination.

ABHD11-AS1 Suppresses Colorectal Cancer Progression by Disrupting EIF4E-mediated POU2F1 Ubiquitination.

Journal: International journal of biological sciences

Published: September 25, 2025

Targeting cell death: a promising approach for colorectal cancer therapy.

Targeting cell death: a promising approach for colorectal cancer therapy.

Journal: Cancer cell international

Published: September 24, 2025

Correction: Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts.

Correction: Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts.

Journal: Frontiers in pharmacology

Published: August 02, 2025

Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment.

Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment.

Journal: Molecular cancer

Published: June 06, 2025

Plasma exosomal miR-483-3p induces myocardial injury by suppressing autophagy via targeting XPO1 in OSA.

Plasma exosomal miR-483-3p induces myocardial injury by suppressing autophagy via targeting XPO1 in OSA.

Journal: Life sciences

Published: April 24, 2025

Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential.

Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: January 23, 2025

Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance.

Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance.

Journal: International journal of biological sciences

Published: December 30, 2024

Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis.

Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis.

Journal: Cell death & disease

Published: December 10, 2024

Mechanism and application of lactylation in cancers.

Mechanism and application of lactylation in cancers.

Journal: Cell & bioscience

Published: November 22, 2024

Fusion genes in cancers: Biogenesis, functions, and therapeutic implications.

Fusion genes in cancers: Biogenesis, functions, and therapeutic implications.

Journal: Genes & diseases

Published: September 10, 2024

Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.

Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.

Journal: International journal of oncology

Published: September 05, 2024

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment.

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment.

Journal: Biomarker research

Published: July 29, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026